|
|
||||||||||
|
J Am Coll Cardiol, 1999; 34:1878-1883 © 1999 by the American College of Cardiology Foundation |





* Division of Cardiology, Department of Medicine, University of Oulu, Oulu, Finland
University of Miami School of Medicine, Miami, Florida, USA
Manuscript received February 28, 1999; revised manuscript received July 2, 1999, accepted September 1, 1999.
Reprint requests and correspondence: Dr. Heikki V. Huikuri, Division of Cardiology, Department of Medicine, University of Oulu, Kajaanintie 50, 90220, Oulu, Finland.
heikki.huikuri{at}oulu.fi
OBJECTIVES
The objectives of this review are to discuss the diversity of mechanisms that may explain the association between heart rate (HR) variability and mortality, to appraise the clinical applicability of traditional and new measures of HR variability and to propose future directions in this field of research. There is a large body of data demonstrating that abnormal HR variability measured over a 24-h period provides information on the risk of subsequent death in subjects with and without structural heart disease. However, the mechanisms responsible for this association are not completely established. Therefore, no specific therapy is currently available to improve the prognosis for patients with abnormal HR variability. Reduced HR variability has been most commonly associated with a risk of arrhythmic death, but recent data suggest that abnormal variability also predicts vascular causes of death, progression of coronary atherosclerosis and death due to heart failure. A consensus is also lacking on the best HR variability measure for clinical purposes. Time and frequency domain measures of HR variability have been most commonly used, but recent studies show that new analysis methods based on nonlinear dynamics may be more powerful in terms of risk stratification. Before the measurement of HR variability can be applied to clinical practice and used to direct therapy, more precise insight into the pathophysiological link between HR variability and mortality are needed. Further studies should also address the issue of which of the HR variability indexes, including the new nonlinear measures, is best for clinical purposes in various patient populations.
| ||||||||||
This article has been cited by other articles:
![]() |
B de la Cruz Torres, C L. Lopez, and J N. Orellana Analysis of heart rate variability at rest and during aerobic exercise: a study in healthy people and cardiac patients Br. J. Sports Med., September 1, 2008; 42(9): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hettema, H. Bootsma, and C. G. M. Kallenberg Macrovascular disease and atherosclerosis in SSc Rheumatology, May 1, 2008; 47(5): 578 - 583. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Billman Heart rate response to onset of exercise: evidence for enhanced cardiac sympathetic activity in animals susceptible to ventricular fibrillation Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H429 - H435. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Y K Wong, S McSwiggan, N S J Kennedy, S Y S Wong, A Gavin, R S MacWalter, and A D Struthers Spectrum of cardiac abnormalities associated with long QT in stroke survivors Heart, October 1, 2005; 91(10): 1306 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Smith, M. Kukielka, and G. E. Billman Heart rate recovery after exercise: a predictor of ventricular fibrillation susceptibility after myocardial infarction Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1763 - H1769. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Ricardo, M. B. de Almeida, B. A. Franklin, and C. G. S. Araujo Initial and Final Exercise Heart Rate Transients: Influence of Gender, Aerobic Fitness, and Clinical Status Chest, January 1, 2005; 127(1): 318 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Freccero, H. Svensson, S. Bornmyr, P. Wollmer, and G. Sundkvist Sympathetic and Parasympathetic Neuropathy Are Frequent in Both Type 1 and Type 2 Diabetic Patients Diabetes Care, December 1, 2004; 27(12): 2936 - 2941. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Rozman and M Bunc Modulation of visceral function by selective stimulation of the left vagus nerve in dogs Exp Physiol, November 1, 2004; 89(6): 717 - 725. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Kiviniemi, A. J. Hautala, T. Seppanen, T. H. Makikallio, H. V. Huikuri, and M. P. Tulppo Saturation of high-frequency oscillations of R-R intervals in healthy subjects and patients after acute myocardial infarction during ambulatory conditions Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1921 - H1927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tulppo and H. V. Huikuri Origin and significance of heart rate variability J. Am. Coll. Cardiol., June 16, 2004; 43(12): 2278 - 2280. [Full Text] [PDF] |
||||
![]() |
H. V. Huikuri, T. H. Makikallio, M. J. P. Raatikainen, J. Perkiomaki, A. Castellanos, and R. J. Myerburg Prediction of Sudden Cardiac Death: Appraisal of the Studies and Methods Assessing the Risk of Sudden Arrhythmic Death Circulation, July 8, 2003; 108(1): 110 - 115. [Full Text] [PDF] |
||||
![]() |
A. R. Schwartz, W. Gerin, K. W. Davidson, T. G. Pickering, J. F. Brosschot, J. F. Thayer, N. Christenfeld, and W. Linden Toward a Causal Model of Cardiovascular Responses to Stress and the Development of Cardiovascular Disease Psychosom Med, January 1, 2003; 65(1): 22 - 35. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. V. Huikuri, A. Castellanos, and R. J. Myerburg Sudden Death Due to Cardiac Arrhythmias N. Engl. J. Med., November 15, 2001; 345(20): 1473 - 1482. [Full Text] [PDF] |
||||
![]() |
J. Gerritsen, J. M. Dekker, B. J. TenVoorde, P. J. Kostense, R. J. Heine, L. M. Bouter, R. M. Heethaar, and C. D.A. Stehouwer Impaired Autonomic Function Is Associated With Increased Mortality, Especially in Subjects With Diabetes, Hypertension, or a History of Cardiovascular Disease: The Hoorn Study Diabetes Care, October 1, 2001; 24(10): 1793 - 1798. [Abstract] [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |